otid and coronary disease are needed. The estimates in these comparisons were highly imprecise. Considering that
blinding of patients and surgeons is not feasible in
studies of carotid disease, we encourage the blinding of
outcome assessors and data analysts, which is possible
and highly desirable to decrease the risk of bias. Studies
that compare the outcomes and cost effectiveness of
carotid screening are also needed.

CONCLUSIONS
This systematic review supports the SVS clinical